Topic: Osi Pharmaceuticals Inc.
Astellas begins $3.5B tender offer for OSI Pharmaceuticals, files lawsuit to stem interferenceJapanese drugmaker Astellas Pharma Inc. said Tuesday it has launched its unsolicited $3.5 billion takeover bid for the U.S. biotech company OSI Pharmaceuticals I